Article

Rapid Influenza Antigen Test for Diagnosis of Pandemic (H1N1) 2009

California Department of Public Health, Richmond, California 94804, USA.
Emerging Infectious Diseases (Impact Factor: 7.33). 05/2010; 16(5):824-6. DOI: 10.3201/eid1605.091797
Source: PubMed

ABSTRACT We compared the QuickVue Influenza test with PCR for diagnosing pandemic (H1N1) 2009 in 404 persons with influenza-like illness. Overall sensitivity, specificity, and positive and negative predictive values were 66%, 84%, 84%, and 64%, respectively. Rapid test results should be interpreted cautiously when pandemic (H1N1) 2009 virus is suspected.

0 Followers
 · 
137 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Western industrialised nations face a large increase in the number of older people. People over the age of 60 years account for almost half of the 16.8 million hospital admissions in England from 2009 to 2010. During 2009-10, respiratory infections accounted for approximately 1 in 30 hospital admissions and 1 in 20 of the 51.5 million bed-days.
    Health technology assessment (Winchester, England) 05/2014; 18(36):1-274. DOI:10.3310/hta18360 · 5.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effectiveness of the 2011-2012 seasonal influenza vaccine was evaluated in adult Korean populations with regard to how well it could prevent laboratory-confirmed influenza and influenza-related complications. A retrospective case-control and retrospective cohort study was conducted among patients who visited four selected hospitals from September 2011 to May 2012. The analysis included 1,130 laboratory-confirmed influenza patients. For each influenza case, one control patient was chosen at a ratio of 1:1. A control was defined as an age group-matched patient who visited the same hospital with influenza-like illness within 48 hours of symptom onset but for whom laboratory tests were negative for influenza. Age group and visit date were matched between the cases and controls. Vaccine effectiveness (VE) was defined as [100 × (1-odds ratio for influenza in vaccinated versus non-vaccinated persons)]. The patients with laboratory-confirmed influenza were followed for at least one month through reviewing the medical records and conducting a telephone interview. The VE of the 2011-2012 seasonal influenza vaccine was 3.8% [95% confidence interval (CI), -16.5% to 20.6%] for preventing laboratory-confirmed influenza, -16.1% (95% CI, -48.3 to 9.1) for influenza A and 26.2% (95% CI, -2.6 to 46.2) for influenza B. The age-specific adjusted VE was 0.3% (95% CI, -29.4 to 23.1) among participants aged 19 to 49 years, 11.9% (95% CI, -34.3 to 42.2) among those aged 50 to 64 years and -3.9% (-60.1 to 32.5) among those aged ≥65 years. The adjusted VE for preventing any influenza-related complications was -10.7% (95% CI, -41.1% to 42.2%). The 2011-2012 seasonal influenza vaccine was not effective in preventing laboratory-confirmed influenza or influenza-related complications in adult Korean populations.
    PLoS ONE 01/2015; 10(3):e0098716. DOI:10.1371/journal.pone.0098716 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Rapid point-of-care (POC) tests provide an economical alternative for rapid diagnosis and treatment of infl uenza, especially in public health emergency situations. Objectives: To test the performance of a rapid infl uenza diagnostic test, QuickVue (Quidel) as a POC test against a real-time polymerase chain reaction (RT-PCR) assay for detection of infl uenza A and B in a developing country setting. Study Design: In a prospective observational design, 600 patients with infl uenza-like illness (ILI) or with severe acute respiratory illness (SARI) who were referred to the Infl uenza Clinic of a tertiary care hospital in Srinagar, India from September 2012 to April 2013, were enrolled for diagnostic testing for infl uenza using QuickVue or RT-PCR. All infl uenza A-positive patients by RT-PCR were further subtyped using primers and probes for A/H1pdm09 and A/H3. Results: Of the 600 patients, 186 tested positive for infl uenza A or B by RT-PCR (90 A/ H1N1pdm09, 7 A/H3 and 89 infl uenza B), whereas only 43 tested positive for infl uenza (infl uenza A = 22 and infl uenza B = 21) by QuickVue. Thus, the sensitivity of the QuickVue was only 23% (95% confi dence interval, CI: 17.3-29.8) and specifi city was 100% (95% CI: 99.1-100) with a positive predictive value (PPV) of 100% (95% CI 91.8-100) and a negative predictive value (NPV) of 74.3% (95% CI: 70.5-77.9) as compared to RT-PCR. Conclusions: The high specifi city of QuickVue suggest that this POC test can be a useful tool for patient management or triaging during a public health crisis but a low sensitivity suggests that a negative test result need to be further tested using RT-PCR
    Indian Journal of Medical Microbiology 02/2015; 33 (supplement 1)(2):26-31. DOI:10.4103/0255-0857.148831 · 1.04 Impact Factor

Preview

Download
2 Downloads
Available from